Cormorant Asset Management’s Monte Rosa Therapeutics GLUE Stock Holding History

Cormorant Asset Management’s Portfolio GLUE Stock Details GLUE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.58M	Buy
2023 Q2	–	Sell
2023 Q1	$22.5M	Hold
2022 Q4	$22M	Sell
2022 Q3	$24.5M	Hold
2022 Q2	$28.9M	Sell
2022 Q1	$42.1M	Hold
2021 Q4	$61.3M	Sell
2021 Q3	$68M	Sell
2021 Q2	$69.5M	Buy